Showing results (51-60 of 75) with videos related to
Sort By:
Pageof 8
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 5, 2024
[<sup>18</sup>F]Fluorthanatrace PET in Ovarian Cancer: Comparison with [<sup>18</sup>F]FDG PET, Lesion Location, Tumor Grade, and Breast Cancer Gene Mutation StatusJoanna K Weeks, Austin R Pantel, Sarah B Gitto, et al.Science Signaling|December 21, 2021
Induction of <i>IL19</i> expression through JNK and cGAS-STING modulates DNA damage-induced cytokine productionSara H Small, E Jessica Tang, Ryan L Ragland, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 1, 2018
Dual Src and MEK Inhibition Decreases Ovarian Cancer Growth and Targets Tumor Initiating Stem-Like CellsFiona Simpkins, Kibeom Jang, Hyunho Yoon, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 21, 2015
MAPK Activation Predicts Poor Outcome and the MEK Inhibitor, Selumetinib, Reverses Antiestrogen Resistance in ER-Positive High-Grade Serous Ovarian CancerKarina E Hew, Philip C Miller, Dorraya El-Ashry, et al.Cancer|January 16, 2025
Olaparib as treatment for platinum-sensitive relapsed ovarian cancer by BRCA mutation and homologous recombination deficiency: Phase 2 LIGHT study final overall survival analysisYing L Liu, Cara A Mathews, Fiona Simpkins, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 17, 2021
Kinetic and Static Analysis of Poly-(Adenosine Diphosphate-Ribose) Polymerase-1-Targeted <sup>18</sup>F-Fluorthanatrace PET Images of Ovarian CancerAnthony J Young, Austin R Pantel, Varsha Viswanath, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 26, 2023
A B7-H4-Targeting Antibody-Drug Conjugate Shows Antitumor Activity in PARPi and Platinum-Resistant Cancers with B7-H4 ExpressionSarah B Gitto, Margaret Whicker, Gareth Davies, et al.Cancer|May 1, 2021
Phase 1 trial of nelfinavir added to standard cisplatin chemotherapy with concurrent pelvic radiation for locally advanced cervical cancerArlene E Garcia-Soto, Nathalie D McKenzie, Margaret E Whicker, et al.Research Square|February 27, 2024
Targeting <i>CCNE1</i> amplified ovarian and endometrial cancers by combined inhibition of PKMYT1 and ATRHaineng Xu, Erin George, David Gallo, et al.Targeted Oncology|June 6, 2023
A Phase Ib Study Assessing the Safety, Tolerability, and Efficacy of the First-in-Class Wee1 Inhibitor Adavosertib (AZD1775) as Monotherapy in Patients with Advanced Solid TumorsTodd M Bauer, Kathleen N Moore, Janet S Rader, et al.Pageof 8